Leukoreduction
Transfusion • Category : Leukoreduction

LEUCOFLEX In-line Whole blood leukoreduction filters

The use of leukoreduction is a major step to improve transfusion safety thanks to a significant reduction of patient adverse reactions and pathogen transmissions.
Macopharma develops and manufactures leukoreduction systems to improve the quality and the safety of blood components, allowing better patient outcome.

Giving you the flexibility to fit your processing conditions to better meet your needs

Leucoflex LXT enables the filtration up to 24 hours after collection at ambient temperature of
a 500mL unit of whole blood within 30 minutes

Leucoflex MTL1 enables the filtration up to 24 hours after collection at ambient temperature of
a 500mL unit of whole blood and even up to 72 hours after collection when filtered in cold conditions

FQE system with LXT filter for leucoreduced plasma
and leucoreduced Red Blood Cells concentrate preparation

DQE system with MTL1 filter for leucoreduced plasma
and leucoreduced Red Blood Cells concentrate preparation

Benefits

High leukoreduction performance
• Leucoflex LXT provides high performance far below the European requirement of < 1 x 106 WBC/unit
• Leucoflex MTL1 provides reliable performance below the AABB requirement of < 5 x 106 WBC/unit

High whole blood recovery > 90%

Quality

Leucoflex MTL1 and LXT filters are used in more than 25 countries worldwide.
Macopharma is a major global player in the filtration of blood components, with unique know-how
and expertise. We have a deep understanding of your requirements and strive to provide you with
reliable and robust filters, guaranteeing high performance stability and reproducibility

Features

Design allowing visual monitoring during filtration

Fast filtration process

Other products in Leukoreduction
Red Cells (In-line / Dockable)
PLASMAFLEX In-line Plasma leukoreduction filter
Menu